BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11780440)

  • 1. Therapeutic antitumor response to cervical cancer in mice immunized with U14 vaccines transfected with costimulatory B7 gene.
    Tao G; Hu J; Zou H; Lin Q; Liu F; Wu Y; Sun Q
    Chin Med J (Engl); 2001 Jun; 114(6):623-7. PubMed ID: 11780440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-tumor immune response to cervical carcinoma induced by costimulatory molecule B7 gene in mice].
    Tao G; Zou H; Hu J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):111-4. PubMed ID: 11783347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-modification of IL-2-TNF alpha fusion gene and B7.1 gene to murine breast tumor cells leads to improved tumor rejection and vaccine effect.
    Liu X; Zhang L; Zhang M; Ma Y; Xu X; Cai Y
    Chin Med J (Engl); 2000 Feb; 113(2):167-71. PubMed ID: 11775545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies of a retrovirus versus a poxvirus vector in whole tumor-cell vaccines.
    Hodge JW; Schlom J
    Cancer Res; 1999 Oct; 59(20):5106-11. PubMed ID: 10537283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine.
    Guinn BA; DeBenedette MA; Watts TH; Berinstein NL
    J Immunol; 1999 Apr; 162(8):5003-10. PubMed ID: 10202049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T; Martuza RL; Dallman MJ; Rabkin SD
    Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation between rejection of tumor cells co-expressing interleukin-2 and B7.1 and vaccine efficiency.
    Cayeux S; Richter G; Becker C; Beck C; Aicher A; Pezzutto A; Dörken B; Blankenstein T
    Eur J Immunol; 1997 Jul; 27(7):1657-62. PubMed ID: 9247574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules.
    Liu Y; Wang H; Zhao J; Ma J; Wei L; Wu S; Xie T; Shen F; Trojan J; Habib N; Anthony DD; Wu M; Guo Y
    Cancer Gene Ther; 2000 Mar; 7(3):456-65. PubMed ID: 10766352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines.
    Cayeux S; Beck C; Aicher A; Dörken B; Blankenstein T
    Eur J Immunol; 1995 Aug; 25(8):2325-31. PubMed ID: 7545119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor effect of murine renal cell carcinoma cells genetically modified to express B7-1 combined with cytokine secreting fibroblasts.
    Wang J; Nakamoto T; Kasaoka Y; Usui T; Hamada H
    Hiroshima J Med Sci; 2000 Mar; 49(1):73-82. PubMed ID: 10824460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth behavior and metastatic pattern of cervical cancer U14 transfected with human papillomavirus in inbred mouse].
    Tao GS; Yang SB; Lin QH
    Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):515-9. PubMed ID: 12536526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-1 (CD80)-gene transfer combined with interleukin-12 administration elicits protective and therapeutic immunity against mouse hepatocellular carcinoma.
    Tatsumi T; Takehara T; Kanto T; Kuzushita N; Ito A; Kasahara A; Sasaki Y; Hori M; Hayashi N
    Hepatology; 1999 Aug; 30(2):422-9. PubMed ID: 10421650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer.
    Xiang J; Chen Y; Moyana T
    Cancer Gene Ther; 2000 Jul; 7(7):1023-33. PubMed ID: 10917205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.
    Aarts WM; Schlom J; Hodge JW
    Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD80 enhances immunogenicity of cervical carcinoma cells in vitro.
    Kaufmann AM; Gissmann L; Street D; Schreckenberger C; Hunter M; Qiao L
    Cell Immunol; 1996 May; 169(2):246-51. PubMed ID: 8620552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction and maintenance of T-cell response to a nonimmunogenic murine mesothelioma cell line requires expression of B7-1 and the capacity to upregulate class II major histocompatibility complex expression.
    Leong C; Marley J; Loh S; Robinson B; Garlepp M
    Cancer Gene Ther; 1996; 3(5):321-30. PubMed ID: 8894251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of therapeutic T-cell immunity by tumor targeting with soluble recombinant B7-immunoglobulin costimulatory molecules.
    Moro M; Gasparri AM; Pagano S; Bellone M; Tornaghi P; Veglia F; Corti A; Casorati G; Dellabona P
    Cancer Res; 1999 Jun; 59(11):2650-6. PubMed ID: 10363988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.
    Larchian WA; Horiguchi Y; Nair SK; Fair WR; Heston WD; Gilboa E
    Clin Cancer Res; 2000 Jul; 6(7):2913-20. PubMed ID: 10914741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic lymphocyte responses to B7-1 expressing human cancer cell lines.
    Dessureault S; Gallinger S
    J Surg Res; 1996 Jul; 64(1):42-8. PubMed ID: 8806472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells.
    Nishitani MA; Sakai T; Ishii K; Zhang M; Nakano Y; Nitta Y; Miyazaki J; Kanayama HO; Kagawa S; Himeno K
    Cancer Gene Ther; 2002 Feb; 9(2):156-63. PubMed ID: 11857033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.